Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Hazardous Material Labeling and Marking

Active

Federal

Response Deadline07/28/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

323117 - Books PrintingView NAICS

Place of Performance

FORT BLISS, TX, 79918-2527, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 22

subcontract

Response DeadlineJul 28

Submission deadline

Response Deadline

07/28/2026, 05:00:00 PM UTCin 4 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Printing and applying hazard warning labels on medical supply containers in accordance with OSHA HAZCOM, MIL-STD-129, and Medical Marking Standard No. 1 (MMS NO. 1).

Similar Contracts

Same NAICS industry code

LABELThe contract pertains to the supply of a specific pressure-sensitive adhesive label bearing the legend “DO NOT DRINK ALCOHOLIC BEVERAGES WHILE TAKING THIS MEDICATION” or an equivalently worded warning, sized 1.5 inches by 0.375 inches with rounded ends, high gloss finish, and delivered in rolls of 1,000 labels each. A total of 18 rolls are required, for a quantity of 18,000 individual labels, under the NSN 7690-01-254-5797. The labels must be sourced and identified by the bidder with the manufacturer’s part number and source, and the delivery must be completed within 84 days after award. All packaging and technical requirements are governed by the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date depending on the acquisition type. The solicitation, identified as SPE2DS-26-T-262S, was posted on July 23, 2026, with responses due by July 29, 2026, under a NAICS code of 323117 for printing and related support activities. The contracting office is the Medical Supply Chain MD Surg FSF within the Department of Defense, with performance expected at APO 96260-5479 and the primary point of contact being Seth Tootell.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

LABELThis contract, issued under solicitation number SPE8E6-26-T-3859 by the Defense Logistics Agency, mandates the supply of 21 units of item NSN 7690015046901, identified as a Type I (Code M) product with a non-extendable 24-month shelf life, requiring strict compliance with packaging and marking standards including MIL-STD-2073-1E and MIL-STD-129 with special marking code 32 indicating shelf-life status. All items must be palletized per DLA Packaging Requirements for Procurement (RP001), delivered FOB origin within 55 days of the need ship dates, and inspected and accepted at destination with no tolerance for quantity variance. The contract incorporates technical and quality requirements referenced from the DLA Master List of Technical and Quality Requirements, with compliance determined by the master revision in effect on the solicitation or award date. Two delivery locations are specified: Barstow, California and New Cumberland, Pennsylvania, each with unique parcel post and freight shipping addresses, and both shipments must adhere to DLA transportation protocols outlined in Proc Notes C19 and C20. The unit price is set at $3.00 per unit, with total contract value based on 21 units, and the contractor, HEIL TRAILER INTERNATIONAL, LLC, must meet the original required delivery date of October 28, 2026, while also adhering to the earlier need ship dates of July 8, 2026 for Barstow and March 13, 2026 for New Cumberland. Contract data confirms the NAICS code 323117 and designates the Department of Defense as the overseeing federal agency with Nicholas Mahoney as the primary point of contact.

BARSTOW CENTRAL RECEIVING WHSE

POSTED

DEADLINE

PrintingThe District of Columbia Department of Health is forecasting a contract for the printing of maternal and child health materials, including brochures, journals, and pamphlets. This opportunity is listed as a forecast with no solicitation number assigned yet, and it was posted on July 23, 2026. The work is expected to take place within the District of Columbia, though specific location details are not provided. There is no designated set-aside type, NAICS code, or organizational classification specified at this stage. Potential vendors should monitor the official portal for future updates, as this posting serves as an early indicator of upcoming procurement activity rather than an active solicitation. Details on point of contact information are also currently unavailable.

POSTED

DEADLINE

Pre and Post Trip BookletsThe District of Columbia’s Special Education Transportation division is forecasting a contract to supply pre and post trip booklets used by drivers during inspections of school buses. These booklets are essential tools for ensuring compliance with safety protocols before and after each route, supporting the reliable and secure transport of students under special education programs. The contract is not yet solicited, with no solicitation number assigned, and is currently listed as a forecast posted on July 23, 2026, indicating the procurement is in the planning phase. No specific NAICS code, set aside type, or organization type has been designated at this stage, and details such as office address and place of performance are not provided. There is no designated point of contact publicly listed, and further details will likely be released in an upcoming formal solicitation.

Special Education Transportation (SET)

POSTED

DEADLINE

FY26-DOEE-USA-Green Building Code Development resourcesThe contract pertains to the development and dissemination of materials to support engagement around the implementation of the Green Building Code in the District of Columbia for fiscal year 2026. It focuses on creating and providing code resources and handbooks designed to educate and assist stakeholders in understanding and adopting sustainable building practices. The effort includes printing and distribution of these materials to ensure broad accessibility and effective outreach across the community. This initiative is led by the Energy and Environment Agency of the District of Columbia and aims to foster compliance and awareness through targeted educational support. While the solicitation is currently in forecast status with no solicitation number assigned, the posting date indicates planning is underway for future procurement activities. The place of performance and point of contact details are not specified, suggesting further information will be released as the procurement progresses.

Energy and Environment (DOEE)

POSTED

DEADLINE

Education and ProgramsThe District of Columbia Corrections department has issued a forecast for the printing of TAP Handbooks under its Education and Programs initiative, with the opportunity posted on July 23, 2026. This forecast indicates a future procurement opportunity focused on producing educational materials for use within the corrections system, though no solicitation number has been assigned yet and the contract type remains undetermined. The anticipated work will involve high-quality printing services tailored to the specific content and formatting requirements of the TAP Handbooks, likely supporting inmate education, reentry programs, or administrative training initiatives. There is no set-aside information, NAICS code, or organizational type specified at this stage, and the point of contact details are未提供. The place of performance has not been defined, leaving flexibility in where the printing and delivery may occur, though it is expected to align with the operational needs of the District of Columbia Corrections agency. Potential vendors should monitor this forecast for an upcoming formal solicitation that will provide detailed specifications, deadlines, and submission requirements. The UI link provided allows interested parties to track updates and access additional information as it becomes available.

Corrections (DC)

POSTED

DEADLINE

FY26- OZ's Printing JobsThe contract forecast titled FY26 OZ's Printing Jobs is issued by the Zoning Office within the District of Columbia, with a posted date of July 23, 2026. It pertains to printing services required by the agency but does not specify a solicitation number, NAICS code, or type of set aside, indicating this is an early-stage forecast rather than an active procurement. The place of performance and office address details are incomplete, and no point of contact information is provided, suggesting that further details will be released in subsequent solicitations. This forecast signals the agency’s anticipated need for printing services in fiscal year 2026 and serves as a notice to potential vendors to prepare for future bidding opportunities.

POSTED

DEADLINE

Military Shipment Marking & LabelingThe contract requires the application of standardized markings and labels to military shipments in strict compliance with MIL-STD-129, ensuring all packages are properly identified with barcodes, handling codes, and storage instructions to support end-to-end logistics tracking. This work is critical for maintaining supply chain integrity and operational readiness across defense networks, with all labeling executed to exact technical specifications to ensure compatibility with military logistics systems. The performance location is designated as Tampa, Florida, with a zip code of 33621, and the work falls under NAICS code 323117, indicating it involves printing and related support activities for defense applications. This is a subcontract opportunity issued by the Department of Defense under the LSO Combat Vehicles and Armament organization, with a response deadline of August 3, 2026, and a posted date of July 22, 2026. The solicitation is part of a broader effort to unify labeling practices across defense shipments, reducing errors and improving asset visibility. While no set-aside type is specified, bidders must be prepared to meet all federal and military compliance standards, including accuracy in data encoding, durability of labels under environmental stress, and adherence to the latest revision of MIL-STD-129. Failure to comply with marking requirements may result in shipment rejection or delays in critical equipment deployment.

LSO COMBAT VEHICLES AND ARMAMENT

POSTED

DEADLINE

Packaging, Preservation, and Labeling Services

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Military Marking and Container LabelingThe contract pertains to the application of National Stock Number (NSN), unit of issue, and handling codes on shipping containers for medical items, in accordance with MMS No. 1, which replaces MIL-STD-129 for these specific supplies. This requirement ensures standardized labeling and identification practices across all containers shipped under Department of Defense medical logistics operations, enhancing traceability, accuracy, and efficiency in receipt and distribution. Contractors must adhere to updated marking protocols to maintain compliance with current military logistics standards and ensure seamless integration into defense supply chains. Subcontracting opportunities are open under this solicitation, with a response deadline of August 3, 2026, and the primary agency overseeing the procurement is the Defense Logistics Agency under the Department of Defense. The North American Industry Classification System code 323117 identifies the scope to include advertising and promotional materials manufacturing, though the actual work focuses on packaging and labeling compliance for medical materiel. The place of performance is designated as FPO with zip code 96632, indicating delivery coordination through military postal channels. Participation requires strict adherence to technical specifications outlined in MMS No. 1, with no set-aside provisions indicated, making this available to all qualifying subcontractors regardless of business size or status.

Defense Logistics Agency

POSTED

DEADLINE

Medical Blood Group Label Design and ComplianceThe contract pertains to the design and production of adhesive labels for blood products that must comply with both FDA regulations and military standards. Each label must be black on white, measuring exactly 1-7/8 by 1-7/8 inches, and must include a Codabar barcode alongside the expiration date to ensure accurate tracking and safe handling in medical and defense environments. The labels are critical for maintaining the integrity of blood supply chains used by the Department of Defense, requiring strict adherence to specifications for material durability, legibility, and resistance to environmental stressors. Issued under the NAICS code 323117 for printing and related support activities, this subcontract opportunity is managed by the Defense Logistics Agency and has a response deadline of August 3, 2026. Performance is expected at an FPO location with the zip code 96632, indicating potential deployment or logistics operations tied to military installations. The requirement reflects a high-stakes operational need where label accuracy directly impacts patient safety and military readiness, necessitating suppliers with proven experience in regulated label manufacturing and compliance documentation for federal medical applications.

Defense Logistics Agency

POSTED

DEADLINE

Military-Compliant Packaging and Preservation

ASC COMMODITIES DIVISION

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

ERYTHROMYCIN OPHTHALMIErythromycin Ophthalmic Ointment, USP, is a sterile topical medication containing 5 mg of erythromycin per gram in a base of mineral oil and white petrolatum, formulated for ophthalmic use as an RX-only product. Each unit is packaged in single-dose tubes containing 3.5 grams of ointment, with a unit of issue consisting of 24 tubes per package. The product has a total shelf life of 36 months, and upon receipt by the first government activity, it must have a minimum of 31 months of remaining shelf life. Storage requirements specify controlled room temperature between 15°C and 30°C (59°F–86°F), with protection from excessive heat and freezing. All packaging and labeling must strictly conform to Medical Marking Standard No. 1, superseding MIL-STD-129, and commercial packaging must comply with ASTM D3951 unless overridden by DLA’s Master List of Technical and Quality Requirements. The manufacturer is PADAGIS US LLC with NDC 00574-4024-39, and the NSN is 6505-01-189-7090. The contract requires delivery of one package (24 tubes) to Fort Bragg, North Carolina, within 20 days of issuance, with FOB destination and zero tolerance for quantity variance. Delivery must be made via traceable freight methods, excluding parcel post, and packaging must meet all DLA procurement standards including palletization and hazardous material handling per FED-STD-313 where applicable. The item falls under a Type I (Code Q) shelf-life category with a non-extendable 36-month lifespan. The contracting official must submit a referral via EBS to confirm product compliance with FDA regulations, including manufacturer and part number details. The solicitation, issued under SPE2DP-26-T-4260, was posted on July 23, 2026, with a response deadline of July 29, 2026, and the required delivery date is July 14, 2026. All documentation, labeling, and marking must align with DLA’s current technical and quality requirements, and the point of contact for inquiries is James McCullough.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

LORATADINE TABLETSLoratadine tablets 10 mg are being procured in quantities of 2 business units, with each unit containing 500 tablets, for a total of 1,000 tablets under contract SPE2DP-26-T-4248. The product must comply with all technical and quality requirements referenced in the DLA Master List of Technical and Quality Requirements, including packaging and marking standards specified in Medical Marking Standard No. 1, which replaces MIL-STD-129. Packaging must be commercial-grade, with each unit sealed in a container that protects against damage and breakage, and shipped in exterior containers suitable for safe delivery via common carrier at the lowest cost to the destination point. The item is regulated by the FDA and requires storage between 20°C and 25°C (68°F to 77°F), protected from excessive moisture. It has a non-extendable shelf life of 36 months, classified as a TYPE I (CODE Q) item under DLA shelf-life requirements. The manufacturer is OHM Laboratories Inc. with NDC 51660-0526-05, and the distributor is AmerisourceBergen Drug Corp. Delivery is FOB destination within 20 days of contract award with zero tolerance for quantity variance, and inspection and acceptance occur at the delivery point. The NSN is 6505-01-524-9179, and all markings must adhere to the latest MMS No. 1 guidelines available through DLA Troop Support. The contracting official must submit a referral in EBS with manufacturer and bidder details prior to award.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

OMEPRAZOLE EXTENDED-REThe contract specifies the procurement of 20 mg omeprazole extended-release capsules in 90-count bottles, identified by NSN 6505016247068 and NDC 00781-2868-92, manufactured by Sandoz Inc. Each unit must be packaged in sealed commercial containers that protect against damage, with shipping containers meeting commercial standards for safe delivery at the lowest freight rate. Packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and palletization must adhere to DLA’s Packaging Requirements. The product has a 24-month shelf life, with at least 21 months remaining at the time of delivery to the first government activity. All units are subject to strict DLA Master List of Technical and Quality Requirements, which take precedence over ASTM D3951, and must be shipped via the fastest traceable means—parcel post is prohibited. The drug is FDA-regulated, and bidders must be referred for product specialist confirmation. Deliveries are split across multiple locations including Fort Stewart, Georgia and Fort Campbell, Kentucky, with rigid zero variance in quantity and fixed delivery dates in July 2026. Inspection and acceptance occur at destination, with all markings and documentation required to align with government-specific identifiers and freight instructions provided in full detail for each delivery point.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

DEADLINE

DEXAMETHASONE TABLETSThe contract pertains to the procurement of Dexamethasone Tablets, USP, 0.5 mg, in unit dose packaging under the National Stock Number 6505-01-045-0451, with a total quantity of 2 packaging groups, each equivalent to 100 tablets. The supplier must adhere to strict packaging and labeling requirements as defined by Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all units must be sealed in protective containers to ensure integrity during shipment. The product, manufactured by Roxane Labs or Hikma Pharmaceuticals USA Inc. under NDC 00054-8179-25, is regulated by the FDA and requires confirmation via EBS referral. It carries a non-extendable shelf life of 36 months and must be marked in full compliance with the latest Medical Marking Standard. Delivery is required FOB destination within five days of contract award, with zero variance allowed in quantity, and inspection and acceptance occur at the destination point. The solicitation is issued under SPE2DP-26-T-4266, with a response deadline of July 29, 2026, and the sole point of contact is James Foggie at DLA Troop Support, with performance directed to Fort Bragg, NC, 28310.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

RINGER'S INJECTION, LACRINGER'S INJECTION LACTATED USP in 1000 mL units, packaged 12 per pack (1 PG), is procured under contract SPE2DP-26-T-4258 with a total quantity of 21 packs to be delivered within 20 days FOB destination. The product is regulated by the FDA and carries a non-extendable shelf life of 30 months as a TYPE I (CODE P) item. Packaging must comply with Medical Marking Standard No. 1, replacing all prior references to MIL-STD-129, and must ensure protection from damage and breakage during transit. Units must be packed in commercial exterior shipping containers suitable for safe delivery at the lowest carrier rate, with labeling and marking strictly following the latest version of MMS No. 1. The product must be stored at room temperature (25°C), with brief exposure up to 40°C permitted without adverse effects, and must be protected from freezing and excessive heat. The manufacturer is B. BROWN MEDICAL INC with NDC number 00264-7750-00 and part number L7500. Inspection and acceptance occur at the delivery point with zero variance allowed in quantity. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with applicable revisions controlled by the solicitation or award date. Government identification must be removed from non-accepted supplies per RQ011, and procurement is subject to covered defense information provisions. Delivery is to Fort Bragg, NC, with primary point of contact Timothy McCauley at DLA.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

IOHEXOL INJECTIONIOHEXOL INJECTION, USP at 300 mg per milliliter in 150 mL polymer bottles, is being procured in boxes of ten bottles each, with a total quantity of 24 boxes required under contract SPE2DP-26-T-4252. The product is classified as a radiological contrast media and must be stored at controlled room temperature between 20–25°C (68–77°F), with excursions permitted between 15–30°C (59–86°F), and must be protected from strong daylight and direct sunlight and not frozen. It carries a non-extendable shelf life of 36 months and must be packaged and marked in accordance with Medical Marking Standard No. 1, superseding MIL-STD-129. Each unit must be sealed and protected against damage, and shipped in commercial exterior containers suitable for safe transport via common carrier at the lowest cost to the designated delivery point at Fort Bragg, North Carolina. The item is subject to Hazard Communication Standard requirements, necessitating Safety Data Sheets aligned with 29 C.F.R. 1910.1200 and compliant labeling prior to award, along with employee training on the updated standards. Packaging must conform to DLA’s RP001 requirements and federal hazardous material guidelines, and if classified as hazardous under Fed-Std-313, must follow TQ requirement IP025; otherwise, commercial packaging per ASTM D3951 applies, though DLA’s technical requirements take precedence. Delivery is required within five days of order placement, FOB destination, with no variance allowed in quantity. The product is supplied by GE HEALTHCARE INC, identified by NDC 00407-1413-65, and must be shipped by the fastest traceable means, excluding parcel post. The required delivery date is July 24, 2026, with solicitation responses due by July 29, 2026.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

KETAMINE INJECTION, VETKetamine Hydrochloride Injection, USP, in 10 mL multiple-dose vials, is a DEA Schedule C-III controlled substance classified for veterinary use, subject to strict handling and storage requirements including storage in a vault at medically controlled room temperature. The item is regulated by the FDA and must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, with all packaging and labeling aligned to DLA’s Packaging Requirements for Procurement RP001. The product carries a non-extendable 24-month shelf life under RS016 requirements, and each unit must be sealed in commercial-grade containers capable of preventing damage, with palletization and exterior packaging conforming to DLA standards for safe transport via common carrier. Deliveries are required FOB destination within 89 days of contract award, with no tolerance for quantity variance, and must be shipped to the specified military medical logistics hub in Kaiserslautern, Germany, or to APO AE 09227-0000, with inspection and acceptance occurring at the delivery point. The contract, identified by solicitation number SPE2DP-26-T-4257 and NSN 6509-01-712-2920, is issued by the Department of Defense under the Medical Supply Chain Pharm FSA, requiring precise adherence to federal procurement and pharmaceutical handling protocols. The item is procured in a single unit of issue, with a required delivery date of July 23, 2026, and response deadline of July 29, 2026. Only approved vendors—Patterson Veterinary Supply, Inc., Covetrus North America, LLC, and Zoetis Inc.—with authorized part numbers may submit bids. All submissions must include manufacturer details and product specifications for FDA referral via EBS, and the item is subject to Covered Defense Information protocols under RD003. Commercial packaging is mandated, with no government identification to be removed from non-accepted supplies per RQ011, and all markings must conform to the latest Medical Marking Standard No. 1 as published by DLA Troop Support.

All Other Health and Personal Care Retailers

POSTED

DEADLINE

ALBUMIN HUMANALBUMIN HUMAN USP 25% in 50 mL vials is specified for intravenous use only, with a concentration of 25% volume to volume, and is heat treated with included administration accessories such as 18 or 20 gauge needles. Each unit must be free of turbidity and stored at room temperature, with no freezing allowed. The product has a non-extendable shelf life of 36 months and is classified as a TYPE I (CODE Q) item under shelf-life requirements. It is regulated by the FDA, and buyers must ensure proper referral through EBS to confirm bidder and manufacturer details, including NDC numbers for KEDRION BIOPHARMA INC and GRIFOLS USA LLC. Packaging must comply with Commercial standards as specified in the procurement document, conforming to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must be contained in sealed, protective unit containers within suitable commercial shipping containers to ensure safe, low-cost delivery to the destination point. All units must be marked and packaged according to MIL-STD-2073-1E, and the material is subject to RD003 covered defense information provisions. The contract calls for a delivery of exactly 10 packs, each containing one 50 mL vial, totaling 500 mL, to be delivered within five days FOB destination with zero variance allowed. Inspection and acceptance occur at the destination. The solicitation number is SPE2DP-26-T-4249, issued by the Department of Defense’s Medical Supply Chain, with a response deadline of July 29, 2026, and performance is designated for Fort Bragg, NC.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

WATER FOR INJECTIONThe contract specifies the procurement of 10 packages of Water for Injection, Sterile, USP, each package containing 25 sterile 20 mL vials with flip-top closures, for a total of 250 vials. The product must comply with USP standards and be labeled in accordance with the latest Medical Marking Standard No. 1, with packaging conforming to MIL-STD-2073-1E. Storage requirements mandate controlled room temperature between 20 and 25 degrees Celsius, and the item has a non-extendable shelf life of 24 months as per RS016 and RS001 for a Type I (Code M) item. The delivery is FOB destination within 20 days of contract award with zero variance allowed in quantity, and inspection and acceptance occur at the destination. The item is regulated by the FDA, and buyers must submit a referral through EBS including manufacturer and bidder details. Only two approved manufacturers are listed: Hospira Worldwide LLC with NDC 00409-4887-20 and Fresenius Kabi, LLC with NDC 63323-0185-20. The contract is issued under solicitation SPE2DP-26-T-4261, with a response deadline of July 29, 2026, and the NSN is 6505-00-582-5079. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, and provisions for removal of government identification from non-accepted supplies and potential covered defense information apply.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

TOLNAFTATE POWDER, UThe contract specifies the procurement of TOLNAFTATE POWDER USP 1% in 45 gram units, identified by NSN 6505014807897 and NDC 57896-0199-45, supplied by GERI-CARE PHARMACEUTICALS CORP. The item is classified as a TYPE I (CODE Q) medical product with a non-extendable shelf life of 36 months and must be packaged in compliance with the DLA Master List of Technical and Quality Requirements, superseding all other standards including ASTM D3951 and MIL-STD-129. Each unit must be sealed in a protective container and shipped in commercial exterior packages suitable for safe delivery via common carrier at the lowest cost, marked in accordance with Medical Marking Standard No. 1, which replaces all prior military marking requirements. The unit of issue is BT, where one BT equals 45 grams, and each shipment must adhere to strict palletization and labeling guidelines outlined in RP001 and other referenced DLA technical directives. The contract includes three separate line items totaling 28 BT (1,260 grams), with delivery deadlines of July 23, 2026, for 24 BT destined to FPO AP 96694, July 27, 2026, for 3 BT to VILSECK, Germany, and one BT to an unspecified location. All deliveries are FOB destination, with zero variance allowed in quantity, inspection and acceptance occurring upon arrival. Shipment must occur via the fastest traceable means, explicitly prohibiting parcel post, and must comply with hazardous material handling requirements per FED-STD-313 and IP025 if applicable. The contract is issued under solicitation SPE2DP-26-T-4256, with a five-day delivery window, and all packaging and labeling requirements must reflect the latest DLA medical standards, ensuring full traceability, regulatory compliance, and readiness for military medical use.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

MAROPITANT CITRATEMaropitant Citrate 160 mg tablets are supplied in blister packs of four tablets per package, with the unit of issue being a package (PG) of four tablets. The product is a veterinary drug regulated by the FDA and must be stored at controlled room temperature between 20–25°C (68–77°F), with allowable excursions between 15–30°C (59–86°F). It has a non-extendable shelf life of 36 months and must be marked and packaged in strict compliance with the latest Medical Marking Standard No. 1, MIL-STD-129, and ASTM D3951, with DLA Master List of Technical and Quality Requirements taking precedence. Packaging must adhere to DLA procurement requirements, including palletization standards, and must not use parcel post; traceable shipping methods are mandatory. The sole delivery point is Fort Sam Houston, Texas, with a delivery window of 20 days and a required delivery date of July 22, 2026. Quantity is fixed at four packages with no variance permitted. Approved suppliers include Patterson Veterinary Supply, Covetrus North America, and Zoetis Inc., each identified by specific part and NDC numbers. All supplies are subject to inspection and acceptance at the destination, and government use only markings apply. The solicitation is issued under contract number SPE2DP-26-T-4255 by the Department of Defense, Medical Supply Chain PHARM FSA.

All Other Health and Personal Care Retailers

POSTED

DEADLINE

SODIUM CHLORIDE INJSodium Chloride Injection in 10 mL disposable syringes, preservative-free and latex-free, is being procured under solicitation SPE2DP-26-T-4254 with a unit of issue of PG, where one PG equals 30 syringes per tray. The product must comply with stringent DLA packaging and marking standards, specifically Medical Marking Standard No. 1, superseding MIL-STD-129, and must be commercially packaged in sealed unit containers to prevent damage or breakage, with exterior shipping containers ensuring safe and cost-effective delivery to Fort Bliss, Texas. The item is regulated by the FDA and requires referral through EBS for confirmation, with no tolerance for quantity variance—exactly one PG must be delivered. The shelf life is strictly 24 months non-extendable and must be clearly marked per MMS No. 1, which is available online through DLA's logistics portal. The delivery is FOB destination with a 20-day lead time from solicitation award, and shipment must occur via traceable freight methods, excluding parcel post. The material is not classified as hazardous under FED-STD-313 and must be packaged in accordance with ASTM D3951 unless overridden by higher-priority DLA technical requirements. Palletization must conform to RP001 DLA Packaging Requirements, and labeling must include all mandated information per MMS No. 1, including the manufacturer part number 106346 from AmerisourceBergen Drug Corp. The contract specifies the delivery point as W8001Z, 0142 CS BN CO A Composite, Fort Bliss, TX, with an original required delivery date of July 27, 2026, and the solicitation closed on July 29, 2026. All technical, quality, and packaging specifications take precedence over commercial standards, and compliance is mandatory for acceptance.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

DEADLINE